Structure-Activity Relationships of Monomeric C2-Aryl Pyrrolo[2,1-c][1,4]benzodiazepine (PBD) Antitumor Agents

Dyeison Antonow, Maciej Kaliszczak, Gyoung-Dong Kang, Marissa Coffils, Arnaud C. Tiberghien, Nectaroula Cooper, Teresa Barata, Sibylle Heidelberger, Colin H. James, Mire Zloh, Terence C. Jenkins, Anthony P. Reszka, Stephen Neidle, Sylvie M. Guichard, Duncan I. Jodrell, John A. Hartley, Philip W. Howard, David E. Thurston

Research output: Contribution to journalArticlepeer-review

Abstract

A comprehensive SA R investigation of the C2-position of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) monomer antitumor agents is reported, establishing the molecular requirements for optimal in vitro cytotoxicity and DNA-binding affinity. Both carbocyclic and heterocyclic C2-aryl substituents have been studied ranging from single aryl rings to fused ring systems, and also styryl substituents, establishing across a library of 80 analogues that C2-aryl and styryl substituents significantly enhance both DNA-binding affinity and in vitro cytotoxicity, with a correlation between the two. The optimal C2-grouping for both DNA-binding affinity and cytotoxicity was found to be the C2-quinolinyl moiety which, according to molecular modeling, is due to the overall fit of the molecule in the DNA minor groove, and potential specific contacts with functional groups in the floor and walls of the groove. This analogue (14l) was shown to delay tumor growth in a HCT-116 (bowel) human tumor xenograft model.

Original languageEnglish
Pages (from-to)2927-2941
Number of pages15
JournalJournal of Medicinal Chemistry
Volume53
Issue number7
DOIs
Publication statusPublished - 8 Apr 2010

Cite this